The Health Resources and Services Administration is reminding hospitals that participate in the 340B drug savings program that they must recertify by Dec. 6 or they will be terminated from the program. HRSA is required to recertify annually all participating covered entities enrolled in the 340B program to ensure they are appropriately listed on the 340B database and that covered entities remain compliant with the 340B program requirements. This year, HRSA unveiled a new recertification process, and any hospital that recertified or started the recertification process before Nov. 3 must complete a new recertification by Dec. 6. For questions about the recertification process, please visit https://www.hrsa.gov/opa/340b-opais/index.html or contact the 340B Prime Vendor Program at (888) 340-2787 or at apexusanswers@340pvp.com

Related News Articles

Headline
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
The AHA today participated in a panel discussion during a conference hosted by The Capitol Forum on the impact of insurer vertical integration. Molly Smith,…
Headline
The Department of Health and Human Services Office of Inspector General yesterday issued an alert warning of marketing schemes by certain Medicare Advantage…
Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…